Insider · CIK 0001987062
Kathleen Borthwick
cfoofficer
Files at PASG (Passage BIO, Inc.). First filing Feb 12, 2025, latest Feb 12, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1,686 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PASG: Passage BIO, Inc.
PASGOct 9, 2026 · close 3.69
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 15, 2025 | PASG Passage BIO, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +278,386 | $0.00 | $0 | 278,386 | Mar 18, 2025 |
| Feb 10, 2025 | PASG Passage BIO, Inc. | MOption exercise Common Stock | +8,000 | - | - | 44,466 | Feb 12, 2025 |
| Feb 11, 2025 | PASG Passage BIO, Inc. | SOpen-market sale Common Stock | -3,183 | $0.53 | $1,686 | 41,283 | Feb 12, 2025 |
| Feb 10, 2025 | PASG Passage BIO, Inc. | MOption exercise Restricted Stock Unitderivative | -8,000 | $0.00 | $0 | 0 | Feb 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.